Enhancing patient centricity in clinical trials through connected devices and digitized data collection: key considerations for sponsors, sites and patients

Industry stakeholders have worked to enhance patient centricity in research and development in recent years in hopes of improving patient engagement and ensuring they have a stronger voice in their clinical care.

This noticeable shift toward patient centricity also intends to help sponsors address long-standing challenges in successfully designing and executing clinical trials. Decentralized trial solutions are being validated in terms of accommodating patients' needs to improve their trial experiences while also benefiting sponsors in reducing trial delays and related costs while not compromising patient safety or data quality.

Key Take-Aways

• Better understand clinical and operational considerations for sponsors, site teams and patients regarding connected devices and wearables and related efficient data collection.
• Develop a detailed strategy early into trial design to effectively manage the large volume of data coming in from these devices and other sources as well and how to ensure extracted insights can optimize decision making.
• Having a comprehensive end to end data flow solution to support all of the data flow components and aid drug discovery and be able to accelerate decision making.

Speaker's:

Sabrina Steffen
Head of Data Strategy and Innovation for DSSM

Greg Temesi
Senior Director, Connected Devices